The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Prevention Point Philadelphia, a nonprofit, has been on the front lines of harm reduction for more than 30 years.

编者按：作为亚太地区最有影响力的艾滋病学科大会之一，第十届亚太艾滋病和合并感染会议（APACC）将于2025年6月12日至14日在日本举行。本次大会上，有多项中国研究成果入选口头报告环节和壁报环节，将向亚太同道展示中国在艾滋病防治领域的卓越成果。Or ...

The Bohol Provincial Health Office (PHO) has confirmed that all local governments in Bohol — including the capital city of ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

A major win in the fight against HIV infections as the Food and Drug Administration approved a new twice-a-year shot to ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

HIV, or human immunodeficiency virus ... This approach now opens new avenues for investigating viral infection, Cianfrocco says. "Now that we have achieved this defined system, we can continue ...

Gilead Sciences Inc. said it won US approval for a drug to prevent HIV that only has to be given twice a year, making it a ...